Literature DB >> 18641822

[Prevalence of ocular manifestation in 198 patients with rheumatoid arthritis: a retrospective study].

Raphael Guimarães Bettero1, Ricardo Faraco Martinez Cebrian, Thelma Larocca Skare.   

Abstract

PURPOSE: To study the prevalence of eye manifestations in the local rheumatoid arthritis (RA) population, as well as to know if the presence of rheumatoid factor (RF) and antinuclear antibodies (ANA) affect this profile. To study if there is association between eye manifestations and patient's articular functional index, age at diagnosis and illness duration.
METHODS: We reviewed 198 charts of rheumatoid arthritis patients followed-up from 2003 to 2006. They were studied for: prevalence of ophthalmologic manifestations, autoantibody profile, demographic data and Steinbrock's functional index.
RESULTS: Secondary Sjögren's syndrome was seen in 12.1% of the patients being more common in women (p=0.049) and in patients with greater articular damage (p=0.016). Ulcerative keratitis and scleritis appeared in 2% of patients each. Antinuclear antibodies (ANA) and rheumatoid factor (RF) as well as illness duration and age at diagnosis had no influence in the appearance of eye manifestations.
CONCLUSION: Secondary Sjögren syndrome was the most common ocular manifestation in patients with RA, mainly in women and patients with greater joint damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641822     DOI: 10.1590/s0004-27492008000300011

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  4 in total

1.  Sex differential association of dermatomyositis with Sjögren syndrome.

Authors:  Chia-Chun Tseng; Shun-Jen Chang; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Wan-Yu Sung; Ming-Chia Hsieh; Jeng-Hsien Yen
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

2.  Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies.

Authors:  Ammapati Paul Pandian Vignesh; Renuka Srinivasan
Journal:  Clin Ophthalmol       Date:  2015-02-25

3.  Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis.

Authors:  Yusuke Nishio; Hiroko Taniguchi; Ayaka Takeda; Junko Hori
Journal:  Int J Mol Sci       Date:  2021-12-29       Impact factor: 5.923

Review 4.  Rheumatoid Arthritis Associated Episcleritis and Scleritis: An Update on Treatment Perspectives.

Authors:  Veronique Promelle; Vincent Goeb; Julie Gueudry
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.